Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-based versus clinical factor-based warfarin initiation after mechanical prosthetic heart valve replacement
ChiCTR-TRC-12002286Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in Cardiac valve disease (VHD) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Time to steady dosage and First time to treatment window. Started Jun 2012; status: completed.
02
Drugs
warfarin
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR-TRC-12002286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002286.